A Trial to Learn if Fianlimab and Cemiplimab Are Safe and Work Better Than Anti-PD1 Alone in Adult Participants With Resectable Stage 3 or 4 Melanoma

PHASE2RecruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

September 18, 2024

Primary Completion Date

March 11, 2027

Study Completion Date

April 23, 2031

Conditions
Melanoma
Interventions
DRUG

cemiplimab

Administered per the protocol

DRUG

Fixed Dose Combination (FDC) cemiplimab+fianlimab

Or coadministration, depending on availability.

DRUG

Placebo

Administered per the protocol

Trial Locations (54)

2065

RECRUITING

Melanoma Institute of Australia, Wollstonecraft

2145

RECRUITING

Westmead Hospital, Westmead

2480

RECRUITING

Lismore Base Hospital, Lismore

3052

RECRUITING

Peter MacCallum Cancer Centre, Melbourne

3128

RECRUITING

Eastern Health, Box Hill

4655

RECRUITING

Hervey Bay Hospital, Hervey Bay

5011

RECRUITING

The Queen Elizabeth Hospital, Woodville

6009

RECRUITING

One Clinical Research at Hollywood Private Hospital, Nedlands

10117

RECRUITING

Charite University Medicine, Berlin

11040

RECRUITING

Northwell Health Cancer Institute, Lake Success

13385

RECRUITING

Hopital Timone, Marseille

14000

RECRUITING

Centre Francois Baclesse, Caen

15213

RECRUITING

University of Pittsburgh, Pittsburgh

19107

RECRUITING

Thomas Jefferson University Hospital, Philadelphia

21000

RECRUITING

CHU-Dijon, Dijon

22908

RECRUITING

University of Virginia, Charlottesville

27710

RECRUITING

Duke Cancer Institute, University Hospital, Durham

30322

RECRUITING

Emory Healthcare, Emory Clinic, Atlanta

33075

RECRUITING

Chu De Bordeaux, Bordeaux

35385

RECRUITING

University Hospital Giessen, Giessen

37007

RECRUITING

Hospital Clinico Universitario de Salamanca, Salamanca

37044

RECRUITING

CHRU de Tours, Tours

37920

RECRUITING

University of Tennessee Medical Center, Knoxville

44106

RECRUITING

Seidman Cancer Center, Cleveland

44124

RECRUITING

Azienda Ospedaliero-Universitaria Ferrara, Cona

44195

RECRUITING

Cleveland Clinic Foundation, Cleveland

56126

RECRUITING

U.O. Oncologia Medica 2 Universitaria, Azienda Ospedaliero Universitaria Pisana, Pisa

59037

RECRUITING

Regional University Hospital of Lille 2208, Lille

60201

RECRUITING

NorthShore University HealthSystem, Evanston

63003

RECRUITING

CHU Estaing, Clermont-Ferrand

63110

RECRUITING

Washington University School of Medicine, St Louis

75010

RECRUITING

Saint Louis Hospital, Paris

77030

RECRUITING

University of Texas MD Anderson Cancer Center, Houston

90089

RECRUITING

Usc Norris Comprehensive Cancer Center, Los Angeles

90404

RECRUITING

St John's Cancer Institute, Santa Monica

92093

RECRUITING

UC San Diego, La Jolla

92104

RECRUITING

Hopital Ambroise Pare, Boulogne

92663

RECRUITING

Hoag Family Cancer Institute, Newport Beach

94115

RECRUITING

California Pacific Medical Center Research Institute, San Francisco

94143

RECRUITING

University of California San Francisco (UCSF), San Francisco

94800

RECRUITING

Gustave Roussy, Villejuif

06102

RECRUITING

Hartford Hospital, Hartford

02114

RECRUITING

Massachusetts General Hospital, Boston

02215

RECRUITING

Dana Farber Cancer Institute Brookline Avenue, Boston

01655

RECRUITING

University of Massachusetts Chan Medical School, Worcester

08901

RECRUITING

Rutgers Cancer Institute of New Jersey, New Brunswick

M5G 2M9

RECRUITING

Princess Margaret Cancer Centre, Toronto

H2X 0C1

RECRUITING

Centre Hospitalier de l'Universite de Montreal (CHUM), Montreal

G1J1Z4

RECRUITING

CHU de Quebec - Universite Laval, Québec

06202

RECRUITING

Centre Hospitalier Universitaire De Nice Hopital De L Archet, Nice

04103

RECRUITING

Universitatsklinikum Leipzig, AoR, Leipzig

08028

RECRUITING

Instituto Oncologico Dr Rosell, Barcelona

08029

RECRUITING

Vall d'Hebron Hospital, Barcelona

08036

RECRUITING

Hospital Clinic de Barcelona, Barcelona

All Listed Sponsors
lead

Regeneron Pharmaceuticals

INDUSTRY